Taking everything into account, VERA scores 2 out of 10 in our fundamental rating. VERA was compared to 525 industry peers in the Biotechnology industry. VERA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VERA is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

VERA had negative earnings in the past year.
VERA had a negative operating cash flow in the past year.
In the past 5 years VERA always reported negative net income.
In the past 5 years VERA always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -48.68%, VERA is in line with its industry, outperforming 52.38% of the companies in the same industry.
VERA's Return On Equity of -63.16% is in line compared to the rest of the industry. VERA outperforms 59.62% of its industry peers.

		Industry Rank	Sector Rank
ROA	-48.68%
ROE	-63.16%
ROIC	N/A

ROA(3y)-48.55%

ROA(5y)-56.49%

ROE(3y)-78.86%

ROE(5y)-77.96%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VERA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, VERA has more shares outstanding
Compared to 5 years ago, VERA has more shares outstanding
Compared to 1 year ago, VERA has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 11.54 indicates that VERA is not in any danger for bankruptcy at the moment.
VERA's Altman-Z score of 11.54 is amongst the best of the industry. VERA outperforms 84.00% of its industry peers.
VERA has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
VERA's Debt to Equity ratio of 0.19 is on the low side compared to the rest of the industry. VERA is outperformed by 65.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Altman-Z	11.54

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

VERA has a Current Ratio of 12.21. This indicates that VERA is financially healthy and has no problem in meeting its short term obligations.
VERA has a better Current ratio (12.21) than 87.05% of its industry peers.
A Quick Ratio of 12.21 indicates that VERA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 12.21, VERA belongs to the top of the industry, outperforming 87.05% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	12.21
Quick Ratio	12.21

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for VERA have decreased strongly by -51.71% in the last year.

EPS 1Y (TTM)-51.71%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-48.24%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

VERA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.98% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-68.42%

EPS Next 2Y-30.47%

EPS Next 3Y-1.83%

EPS Next 5Y38.98%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VERA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VERA. No positive earnings are expected for the next year.